Top Markets
Coin of the day
Pixium Vision S.A. Pixium Vision S.A.

Pixium Vision S.A.

ALPIX
株式のランク #40308
Pixium Vision S.A. is a French company at the forefront of bioelectronics and... Pixium Vision S.A. is a French company at the forefront of bioelectronics and brain-machine interface technology, focusing on neuromodulation applications. The company develops the PRIMA System, a sophisticated bionic vision solution aimed at individuals experiencing profound vision loss due to retinal degeneration, specifically the dry atrophic form of Age-related Macular Degeneration (AMD). This system is engineered to combat blindness by effectively replacing the natural function of the eye's photoreceptor cells. It achieves this by electrically stimulating the nerve cells within the inner retina, which then transmit visual information to the brain via the optic nerve. Pixium Vision has established significant collaborative agreements with esteemed institutions such as Stanford University in California, the Institut de la Vision, Moorfields Eye Hospital, the Institute of Ocular Microsurgery, University Hospital, and UPMC. Founded in 2011, the company is headquartered in Paris, France.
株価
$0.40796816
最終同期: 2024-02-28
時価総額
$181.55K
変化(1日)
-0.06%
変化(1年)
0.00%
FR
取引 Pixium Vision S.A. (ALPIX)

カテゴリー

Pixium Vision S.A.(ALPIX)のEPS
2026 時点のEPS TTM: 0
Pixium Vision S.A.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Pixium Vision S.A.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS